202 related articles for article (PubMed ID: 15158805)
61. Synthesis and antitumor activity of new glycosides of epipodophyllotoxin, analogues of etoposide, and NK 611.
Daley L; Guminski Y; Demerseman P; Kruczynski A; Etiévant C; Imbert T; Hill BT; Monneret C
J Med Chem; 1998 Nov; 41(23):4475-85. PubMed ID: 9804687
[TBL] [Abstract][Full Text] [Related]
62. Amidine analogues of melphalan: synthesis, cytotoxic activity, and DNA binding properties.
Bielawska A; Bielawski K; Anchim T
Arch Pharm (Weinheim); 2007 May; 340(5):251-7. PubMed ID: 17458920
[TBL] [Abstract][Full Text] [Related]
63. Topoisomerase II is a cellular target for antiproliferative cobalt salicylaldoxime complex.
Jayaraju D; Gopal YN; Kondapi AK
Arch Biochem Biophys; 1999 Sep; 369(1):68-77. PubMed ID: 10462441
[TBL] [Abstract][Full Text] [Related]
64. Antitumor agents. 148. Synthesis and biological evaluation of novel 4 beta-amino derivatives of etoposide with better pharmacological profiles.
Zhang YL; Guo X; Cheng YC; Lee KH
J Med Chem; 1994 Feb; 37(4):446-52. PubMed ID: 8120864
[TBL] [Abstract][Full Text] [Related]
65. Synthesis and antitumor activity of 5-(9-acridinylamino)anisidine derivatives.
Bacherikov VA; Chang JY; Lin YW; Chen CH; Pan WY; Dong H; Lee RZ; Chou TC; Su TL
Bioorg Med Chem; 2005 Dec; 13(23):6513-20. PubMed ID: 16140018
[TBL] [Abstract][Full Text] [Related]
66. Synthesis and topoisomerase poisoning activity of A-ring and E-ring substituted luotonin A derivatives.
Nacro K; Zha CC; Guzzo PR; Jason Herr R; Peace D; Friedrich TD
Bioorg Med Chem; 2007 Jun; 15(12):4237-46. PubMed ID: 17418582
[TBL] [Abstract][Full Text] [Related]
67. Structure-based design, synthesis and biological testing of etoposide analog epipodophyllotoxin-N-mustard hybrid compounds designed to covalently bind to topoisomerase II and DNA.
Yadav AA; Wu X; Patel D; Yalowich JC; Hasinoff BB
Bioorg Med Chem; 2014 Nov; 22(21):5935-49. PubMed ID: 25282653
[TBL] [Abstract][Full Text] [Related]
68. Effect of 4 beta-arylamino derivatives of 4'-O-demethylepipodophyllotoxin on human DNA topoisomerase II, tubulin polymerization, KB cells, and their resistant variants.
Chang JY; Han FS; Liu SY; Wang ZQ; Lee KH; Cheng YC
Cancer Res; 1991 Apr; 51(7):1755-9. PubMed ID: 1848478
[TBL] [Abstract][Full Text] [Related]
69. Insight into eukaryotic topoisomerase II-inhibiting fused heterocyclic compounds in human cancer cell lines by molecular docking.
Taskin T; Yilmaz S; Yildiz I; Yalcin I; Aki E
SAR QSAR Environ Res; 2012; 23(3-4):345-55. PubMed ID: 22490049
[TBL] [Abstract][Full Text] [Related]
70. [In vitro stimulation by ellipticine derivatives of DNA cleavage induced by DNA topoisomerase II: a structure-activity relationship].
Fossé P; Charra M; Paoletti C; Saucier JM; René B
Bull Cancer; 1994 Mar; 81(3):194-202. PubMed ID: 7894127
[TBL] [Abstract][Full Text] [Related]
71. Etoposide: discovery and medicinal chemistry.
Meresse P; Dechaux E; Monneret C; Bertounesque E
Curr Med Chem; 2004 Sep; 11(18):2443-66. PubMed ID: 15379707
[TBL] [Abstract][Full Text] [Related]
72. Antitumor agents. Part 232: Synthesis of cyclosulfite podophyllotoxin analogues as novel prototype antitumor agents.
Xiao Z; Han S; Bastow KF; Lee KH
Bioorg Med Chem Lett; 2004 Mar; 14(6):1581-4. PubMed ID: 15006408
[TBL] [Abstract][Full Text] [Related]
73. Synthesis and biological evaluation of new 4beta-anilino- and 4beta-imido-substituted podophyllotoxin congeners.
Kamal A; Gayatri NL; Reddy DR; Mohan Reddy PS; Arifuddin M; Dastidar SG; Kondapi AK; Rajkumar M
Bioorg Med Chem; 2005 Nov; 13(22):6218-25. PubMed ID: 16061385
[TBL] [Abstract][Full Text] [Related]
74. Synthesis and cytotoxic activity of novel amidine analogues of bis(2-chloroethyl)amine.
Bielawski K; Bielawska A; Poplawska B
Arch Pharm (Weinheim); 2009 Aug; 342(8):484-90. PubMed ID: 19565602
[TBL] [Abstract][Full Text] [Related]
75. Synthesis and biological study of a new series of 4'-demethylepipodophyllotoxin derivatives.
Duca M; Guianvarc'h D; Meresse P; Bertounesque E; Dauzonne D; Kraus-Berthier L; Thirot S; Léonce S; Pierré A; Pfeiffer B; Renard P; Arimondo PB; Monneret C
J Med Chem; 2005 Jan; 48(2):593-603. PubMed ID: 15658872
[TBL] [Abstract][Full Text] [Related]
76. Synergistic interaction of proteasome and topoisomerase II inhibition in multiple myeloma.
von Metzler I; Heider U; Mieth M; Lamottke B; Kaiser M; Jakob C; Sezer O
Exp Cell Res; 2009 Aug; 315(14):2471-8. PubMed ID: 19410573
[TBL] [Abstract][Full Text] [Related]
77. L-proline analogues of anthraquinone-2-carboxylic acid: cytotoxic activity in breast cancer MCF-7 cells and inhibitory activity against topoisomerase I and II.
Bielawska A; Kosk K; Bielawski K
Pol J Pharmacol; 2001; 53(3):283-7. PubMed ID: 11785929
[TBL] [Abstract][Full Text] [Related]
78. BN80927: a novel homocamptothecin that inhibits proliferation of human tumor cells in vitro and in vivo.
Demarquay D; Huchet M; Coulomb H; Lesueur-Ginot L; Lavergne O; Camara J; Kasprzyk PG; Prévost G; Bigg DC
Cancer Res; 2004 Jul; 64(14):4942-9. PubMed ID: 15256467
[TBL] [Abstract][Full Text] [Related]
79. Synthesis and biological evaluation of distamycin analogues - new potential anticancer agents.
Drozdowska D; Rusak M; Miltyk W; Midura-Nowaczek K
Arch Pharm (Weinheim); 2009 Feb; 342(2):87-93. PubMed ID: 19173336
[TBL] [Abstract][Full Text] [Related]
80. Cellular response to etoposide treatment.
Montecucco A; Biamonti G
Cancer Lett; 2007 Jul; 252(1):9-18. PubMed ID: 17166655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]